This inability of hypomorphic Myc to support tumour development raises the possibility that long-term reduction in Myc activity in adults, perhaps imposed by some future Myc-inhibitor drug, might be powerfully prophylactic against cancers. The gene discussed is MYC; the disease is cancer.